1. Home
  2. PRAX vs IDA Comparison

PRAX vs IDA Comparison

Compare PRAX & IDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

N/A

Current Price

$327.25

Market Cap

7.1B

Sector

Health Care

ML Signal

N/A

Logo IDACORP Inc.

IDA

IDACORP Inc.

N/A

Current Price

$147.72

Market Cap

8.4B

Sector

Utilities

ML Signal

N/A

Company Overview

Basic Information
Metric
PRAX
IDA
Founded
2015
1915
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electric Utilities: Central
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
8.4B
IPO Year
2020
1998

Fundamental Metrics

Financial Performance
Metric
PRAX
IDA
Price
$327.25
$147.72
Analyst Decision
Strong Buy
Buy
Analyst Count
21
9
Target Price
★ $650.00
$154.22
AVG Volume (30 Days)
420.7K
★ 499.9K
Earning Date
11-09-2026
10-29-2026
Dividend Yield
N/A
★ 2.46%
EPS Growth
N/A
★ 7.27
EPS
N/A
★ 5.76
Revenue
N/A
★ $1,746,972,000.00
Revenue This Year
N/A
$11.58
Revenue Next Year
$41,442.59
$8.99
P/E Ratio
★ N/A
$25.38
Revenue Growth
N/A
★ N/A
52 Week Low
$160.11
$124.12
52 Week High
$392.70
$154.91

Technical Indicators

Market Signals
Indicator
PRAX
IDA
Relative Strength Index (RSI) 63.91 67.90
Support Level $307.93 $143.39
Resistance Level $347.63 $149.47
Average True Range (ATR) 16.67 2.43
MACD 5.68 0.53
Stochastic Oscillator 96.95 85.79

Price Performance

Historical Comparison
PRAX
IDA

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About IDA IDACORP Inc.

Idacorp is a holding company for Idaho Power. Idacorp is a vertically integrated utility that generates, transmits, and distributes electricity to 670,000 customers in southern Idaho and eastern Oregon. The utility owns 1.8 gigawatts of hydro generation, 400 MW of coal generation, 1.4 GW of natural gas generation, and 300 MW of energy storage.

Share on Social Networks: